TCD Followed by autoSCT for Newly Diagnosed MM Patients
Status:
Unknown status
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Multiple Myeloma is a incurable disease. Thalidomide in combination with other agents are
currently in trials for the newly diagnosed patients, we designed treatment of TCD, followed
by high dose chemotherapy with autologous stem cell transplantation and TD maintenance
therapy for the patients with newly diagnosed multiple myeloma.